Table 2 Distribution of comorbid conditions or statin use in those without and with elevated hsCRP
Categorical Variables | hsCRP < 2 mg/L (n = 9) | hsCRP ≥ 2 mg/L (n = 16) | P-value |
|---|---|---|---|
History of chemotherapy | 7 (78%) | 14 (88%) | 0.602 |
Cancer type (Breast vs. Lung) | Â | Â | 1.000 |
 Breast cancer | 4 (44%) | 6 (38%) |  |
 Lung cancer | 5 (56%) | 10 (63%) |  |
History of anemia | 1 (11%) | 4 (25%) | 0.621 |
Obesity | 1 (11%) | 6 (38%) | 0.355 |
Hypertension | 4 (44%) | 10 (63%) | 0.434 |
Dyslipidemia | 5 (56%) | 5 (31%) | 0.397 |
Diabetes Mellitus | 1 (11%) | 5 (31%) | 0.364 |
Current Smoker | 2 (22%) | 4 (25%) | 1.000 |
Sedentary Lifestyle | 3 (33%) | 8 (50%) | 0.677 |
Statin Use | 3 (33%) | 5 (31%) | 1.000 |
Hormone therapy | 3 (33%) | 4 (25%) | 0.673 |